Johnson BD, Sackett JR, Sarker S, Schlader ZJ. Face cooling increases blood pressure during central hypovolemia. Am J Physiol Regul Integr Comp Physiol 313: R594 -R600, 2017. First published August 30, 2017 doi:10.1152/ajpregu.00253.2017.-A reduction in central blood volume can lead to cardiovascular decompensation (i.e., failure to maintain blood pressure). Cooling the forehead and cheeks using ice water raises blood pressure. Therefore, face cooling (FC) could be used to mitigate decreases in blood pressure during central hypovolemia. We tested the hypothesis that FC during central hypovolemia induced by lower-body negative pressure (LBNP) would increase blood pressure. Ten healthy participants (22 Ϯ 2 yr, three women, seven men) completed two randomized LBNP trials on separate days. Trials began with 30 mmHg of LBNP for 6 min. Then, a 2.5-liter plastic bag of ice water (0 Ϯ 0°C) (LBNPϩFC) or thermoneutral water (34 Ϯ 1°C) (LBNPϩSham) was placed on the forehead, eyes, and cheeks during 15 min of LBNP at 30 mmHg. Forehead temperature was lower during LBNPϩFC than LBNPϩSham, with the greatest difference at 21 min of LBNP (11.1 Ϯ 1.6 vs. 33.9 Ϯ 1.4°C, P Ͻ 0.001). Mean arterial pressure was greater during LBNPϩFC than LBNPϩSham, with the greatest difference at 8 min of LBNP (98 Ϯ 15 vs. 80 Ϯ 8 mmHg, P Ͻ 0.001). Cardiac output was higher during LBNPϩFC than LBNPϩSham with the greatest difference at 18 min of LBNP (5.9 Ϯ 1.4 vs. 4.9 Ϯ 1.0 liter/min, P ϭ 0.005). Forearm cutaneous vascular resistance was greater during LBNPϩFC than LBNPϩSham, with the greatest difference at 15 min of LBNP (7.2 Ϯ 3.4 vs. 4.9 Ϯ 2.7 mmHg/perfusion units (PU), P Ͻ 0.001). Face cooling during LBNP increases blood pressure through increases in cardiac output and vascular resistance. blood loss; central hypovolemia; human dive reflex; cardiovascular decompensation BLOOD LOSS and other clinical situations (e.g., postural orthostatic intolerance, sepsis, and Dengue fever) can cause central hypovolemia and lead to cardiovascular decompensation (i.e., inability to maintain blood pressure). Several methods aimed at maintaining blood pressure during central hypovolemia have been investigated in the prehospital setting or in the laboratory. Intravenous saline infusions are common in the prehospital setting to counteract central hypovolemia. However, intravenous saline infusions increase the risk of coagulopathy (38) and necessary blood transfusions (18) in trauma patients. Furthermore, this method requires venous access, which can be difficult to obtain during central hypovolemia (13). Respiratory impedance devices improve blood pressure in a variety of models of central hypovolemia (e.g., large animals, healthy volunteers, and patients) (9 -11, 25, 27, 35, 36). However, the patient must have an adequate ventilatory drive for the device to be effective. In this regard, whole body surface skin cooling has also been used to increase blood pressure during central hypovolemia in humans (12, 14, 30) . However, whole body surface skin cooling is impractical for prehospital use due to its size and the need for a power source to chill and circulate the coolant. Therefore, a practical, prehospital technique is needed to prevent or delay cardiovascular decompensation when patients experience central hypovolemia.
BLOOD LOSS and other clinical situations (e.g., postural orthostatic intolerance, sepsis, and Dengue fever) can cause central hypovolemia and lead to cardiovascular decompensation (i.e., inability to maintain blood pressure). Several methods aimed at maintaining blood pressure during central hypovolemia have been investigated in the prehospital setting or in the laboratory. Intravenous saline infusions are common in the prehospital setting to counteract central hypovolemia. However, intravenous saline infusions increase the risk of coagulopathy (38) and necessary blood transfusions (18) in trauma patients. Furthermore, this method requires venous access, which can be difficult to obtain during central hypovolemia (13) . Respiratory impedance devices improve blood pressure in a variety of models of central hypovolemia (e.g., large animals, healthy volunteers, and patients) (9 -11, 25, 27, 35, 36) . However, the patient must have an adequate ventilatory drive for the device to be effective. In this regard, whole body surface skin cooling has also been used to increase blood pressure during central hypovolemia in humans (12, 14, 30) . However, whole body surface skin cooling is impractical for prehospital use due to its size and the need for a power source to chill and circulate the coolant. Therefore, a practical, prehospital technique is needed to prevent or delay cardiovascular decompensation when patients experience central hypovolemia.
Cooling the forehead and cheeks stimulates the trigeminal nerve, which elicits an increase in cardiac parasympathetic activity followed by a rise in sympathetic activity (17) . Despite the transient increase in cardiac parasympathetic activity, face cooling causes substantial increases in blood pressure that can be maintained for 15 min or more (37) . Therefore, simply cooling the forehead and cheeks might be an effective intervention to maintain or improve blood pressure in individuals during acute periods of central hypovolemia. Two minutes of face cooling during central hypovolemia induced by lowerbody negative pressure (LBNP) prevents a decrease in mean arterial pressure (8) . Therefore, the purpose of our study was to test the hypothesis that cooling the forehead, eyes, and cheeks would raise blood pressure for up to 15 min during central hypovolemia in healthy humans.
METHODS
Participants. Ten healthy participants (age: 22 Ϯ 2 yr; three women, seven men; height: 174 Ϯ 10 cm; weight: 73 Ϯ 13 kg) completed the study. Participants self-reported to be free from autonomic, cardiovascular, respiratory, metabolic, or endocrine diseases. All participants self-reported to be nonsmokers and were not taking any medications (except oral contraceptives; n ϭ 1). Women were not pregnant (confirmed by a negative urine pregnancy test), and we did not control for menstrual cycle hormones. All participants were fully informed of the experimental procedures and possible risks before giving informed, written consent. The study was approved by the Institutional Review Board at the University at Buffalo and was performed in accordance with the standards set by the latest revision of the Declaration of Helsinki.
Experimental approach. Participants completed two randomized study visits: one LBNP with face cooling (LBNPϩFC) and one LBNP with sham (LBNPϩSham). For both study visits, we asked participants to report to the temperature-controlled (23 Ϯ 1°C, 21 Ϯ 6% relative humidity) laboratory after abstaining from exercise, alcohol, and caffeine for at least 12 h and food for at least 2 h. After participants were instrumented, we secured them to the LBNP cham-ber in the supine position using a neoprene kayak skirt that was sealed at the level of the iliac crest. After a 10-min rest period, we collected baseline data for an additional 10 min. At the end of baseline, 30 mmHg of LBNP commenced for 6 min. This represents a moderate level of LBNP that elicits central hypovolemia (e.g.,~6.8 mmHg reduction in central venous pressure) and hemodynamic responses that are associated with upward of 1,000 ml of blood loss in humans (21) . Then, we placed a pliable plastic bag filled with ice water (LBNPϩFC) or thermoneutral water (LBNPϩSham) on the forehead, eyes, and cheeks for the next 15 min, while 30 mmHg of LBNP was maintained. The volume of water in the plastic bag was 2.5 liters in both trials, and the bags were agitated every 3 min. After 15 min of face cooling or sham, LBNP was terminated, the plastic bag was removed, and water temperature was measured using a thermocouple (Omega Engineering, Stanford, CT; face cooling: 0 Ϯ 0°C; sham: 34 Ϯ 1°C). After the termination of face cooling or sham, participants remained supine, and we collected 5 min of recovery data.
Instrumentation and measurements. Height and weight were measured using a stadiometer and scale (Sartorius, Bohemia, NY) before the study visits. A three-lead electrocardiogram (DA100C, Biopac Systems, Goleta, CA) was used to continuously record heart rate, and the Penaz method was used to collect beat-to-beat blood pressure (Finometer Pro; FMS, Amsterdam, The Netherlands). Beat-to-beat blood pressure was intermittently confirmed using auscultation of the brachial artery via electrosphygmomanometry (Tango M2; SunTech, Raleigh, NC), and no corrections were needed. Stroke volume was calculated via ModelFlow using the blood pressure waveform (46) . Laser-Doppler flowmetry (Periflux System 5010; Perimed, Stockholm, Sweden) was used to measure skin blood flow on the dorsal side of the left forearm and the pad of the left-hand index finger. Skin blood flow was measured on the fingertip to provide an index of reflex cutaneous vasoconstriction because only cutaneous vasoconstrictor nerves innervate glabrous skin (22) . Both laser-Doppler probes were inserted into thin plastic holders that were adhered to the skin using porous tape. Participants were also instructed to keep their left arm and hand still throughout the protocol. Forearm blood flow was measured in the right arm using venous occlusion plethysmography (48) at 10 min of baseline and every 3 min during LBNP. A strain gauge was placed around the largest circumference of the forearm, and pressure cuffs were secured around the upper arm proximal to the elbow and around the wrist. The wrist cuff was inflated to 250 mmHg, and the upper arm cuff cycled between 0 mmHg and 50 mmHg every 8 s during each measurement period. Forearm blood flow was calculated for each cycle using the slope of the increase in forearm circumference determined by the strain gauge and the average of six cycles at each measurement period was used for statistical analyses (49) . A thermocouple (Omega Engineering, Stanford, CT) was adhered to the forehead using permeable tape (Transpore, 3M, St. Paul, MN) to continuously measure forehead skin temperature.
Data analyses. We recorded data continuously at 1 kHz using a data acquisition system (Biopac MP150, Goleta, CA). Data were analyzed in 1-min segments at 10 min of baseline, at 3 and 6 min of LBNP, during each of the first 3 min of face cooling or sham, and every 3 min thereafter. Recovery data were analyzed in 1-min segments at the end of the 5-min recovery period (Post). We calculated the R-R intervals from the electrocardiogram during each data analysis time point. All R-waves were visually inspected for ectopic beats and manually edited where needed (37) . These analyses were used to estimate changes in short-term cardiac parasympathetic activity using the root mean square of successive differences in R-R intervals (RMSSD) using WinCPRS software (Absolute Aliens, Turku, Finland) (17, 34, 37) . Cardiac output was calculated as the product of heart rate and stroke volume, and total peripheral resistance was calculated as the quotient of mean arterial pressure and cardiac output. Cutaneous, fingertip, and forearm vascular resistances were calculated as the quotient of mean arterial pressure and skin and forearm blood flow, respectively.
Statistical analyses. Two-way repeated-measures ANOVA were used to compare responses between LBNPϩFC and LBNPϩSham (condition effect) and within experimental conditions (time effect). We used the Holm-Sidak post hoc procedure to determine where differences existed if the ANOVA revealed a significant interaction or main effect. Data over time were compared with those acquired at the 10-min baseline. All data were assessed for approximation to a normal distribution and sphericity, and no corrections were made. Statistical analyses were performed using Prism software (version 6, GraphPad Software, La Jolla, CA). Data are reported as means Ϯ SD, and P values are reported.
RESULTS
Forehead skin temperature. There were no differences between conditions in forehead skin temperature at baseline or during the first 6 min of LBNP (Fig. 1 ). Forehead skin temperature was lower than baseline and LBNPϩSham throughout the entire face cooling procedure and 5 min after the cooling stimulus had been removed (P Ͻ 0.001).
Blood pressure. There were no differences in mean arterial pressure between conditions at baseline or during LBNP alone (P Ͼ 0.068) ( Fig. 2A) . During LBNP alone, mean arterial pressure was not different from baseline in either condition (P Ͼ 0.107). Throughout LBNPϩFC, mean arterial pressure was greater than baseline (P Յ 0.001) and LBNPϩSham (P Ͻ 0.019). Mean arterial pressure remained greater than baseline 5 min after LBNPϩFC (P Ͻ 0.001). We did not observe any change from baseline in mean arterial pressure during LBNPϩSham (P Ͼ 0.454). During LBNP alone, systolic blood pressure was lower in both conditions compared with baseline (P Յ 0.005) (Fig. 2B ). Throughout LBNPϩSham, systolic blood pressure remained lower than baseline (P Ͻ 0.035). However, systolic blood pressure returned to baseline values during LBNPϩFC (P Ն 0.123). During LBNPϩFC, systolic blood pressure was greater than LBNPϩSham after 2 min of face cooling and remained greater throughout face cooling (P Ͻ 0.002). Diastolic blood pressure was not different between conditions (condition effect: P ϭ 0.991), nor was there an effect of time (P ϭ 0.379) or interaction (P ϭ 0.056) (Fig. 2C) .
Cardiac responses. The heart rate response during LBNP and LBNPϩSham was not different than baseline throughout the protocol (P Ͼ 0.211) (Fig. 3A) . Heart rate during LBNP alone was greater than baseline during the LBNPϩFC protocol (P Ͻ 0.020), but it returned to baseline values during face cooling (P Ͼ 0.129). There were no differences in heart rate between the conditions (P Ն 0.186) until 2 min (P ϭ 0.030), 3 min (P ϭ 0.014), and 6 min (P ϭ 0.038) of face cooling.
Stroke volume was lower in both conditions during LBNP alone when compared with baseline (P Յ 0.001). Stroke volume remained lower than baseline throughout LBNPϩ Sham (P Ͻ 0.001) (Fig. 3B) . However, stroke volume was restored to baseline values during LBNPϩFC (P Ͼ 0.108). Between conditions, stroke volume was not different during baseline, LBNP alone, or the first minute of face cooling (P Ͼ 0.121). After 2 min of face cooling, stroke volume was greater during LBNPϩFC than LBNPϩSham (P Ͻ 0.001). Cardiac output was lower than baseline throughout the LBNPϩSham protocol (P Ͻ 0.003) and only lower than baseline in LBNPϩFC after 2 min of face cooling (P ϭ 0.004) (Fig. 3C ).
Between conditions, cardiac output was greater in LBNPϩFC at several time points (P Ͻ 0.007).
RMSSD was not different between conditions at baseline or during LBNP alone (P Ͼ 0.563) (Fig. 3D) . During the LBNPϩSham protocol, there were no significant changes in RMSSD from baseline (P Ͼ 0.113). During LBNPϩFC, RMSSD was greater than baseline during the first 6 min of face cooling (P Յ 0.035). RMSSD was also greater in LBNPϩFC than LBNPϩSham from minutes 7 to 18 (P Ͻ 0.026).
Blood flow. Forearm blood flow was lower during LBNPϩ Sham (2.
Ϫ1
) at baseline (P Ͻ 0.005); therefore, we analyzed changes from baseline forearm blood flow. The change in forearm blood flow during LBNPϩSham was lower than baseline at minute 3 only (P Ͻ 0.050) ( Table  1 ). The change in forearm blood flow during LBNPϩFC was lower than baseline throughout the protocol (P Ͻ 0.002). The change in forearm blood flow was greater at minutes 15 and 21 during LBNPϩFC than LBNPϩSham (P Ͻ 0.007).
Forearm cutaneous blood flow was not statistically different between conditions (P ϭ 0.855) or throughout the protocols (P ϭ 0.601), nor was there a significant interaction effect (P ϭ 0.881) ( Table 1) .
Fingertip cutaneous blood flow was greater than baseline during LBNPϩSham after 12 min and throughout the protocol (P Ͻ 0.005) ( Table 1) . Fingertip cutaneous blood flow was lower than baseline at 7 min of LBNPϩFC (P ϭ 0.007). Fingertip cutaneous blood flow was greater during LBNPϩ Sham than LBNPϩFC at minute 7 and from minute 12 to the end of the protocols (P Ͻ 0.020).
Vascular resistance. During LBNPϩSham, total peripheral resistance was greater than baseline throughout the protocol (P Ͻ 0.041) (Fig. 4A) . However, during LBNPϩFC, total peripheral resistance was greater than baseline starting after the first 2 min of face cooling (P Ͻ 0.028). Total peripheral resistance was greater during LBNPϩFC than LBNPϩSham at 2 min of face cooling (P Ͻ 0.008). We obtained a full data set for only seven participants for forearm vascular resistance due to technical difficulties. Forearm vascular resistance was greater during LBNPϩSham (34.7 Ϯ 16.3 mmHg·ml Ϫ1 ·100 g tissue Ϫ1 ·min) than LBNPϩFC (18.1 Ϯ 5.1 mmHg·ml Ϫ1 ·100 g tissue Ϫ1 ·min) at baseline (P Ͻ 0.005); therefore, we analyzed changes from baseline forearm vascular resistance. The change in forearm vascular resistance in LBNPϩSham was greater than baseline throughout the protocol (P Ͻ 0.004) (Fig. 4B) . In LBNPϩFC, the change in forearm vascular resistance was greater than baseline only during face cooling (P Ͻ 0.010). There were no differences in the change from baseline forearm vascular resistance between LBNPϩSham and LBNPϩFC (P Ն 0.060).
During LBNPϩSham, forearm cutaneous vascular resistance did not change from baseline (P Ͼ 0.694) (Fig. 4C) . Forearm cutaneous vascular resistance was greater during LBNPϩFC after 3 min of face cooling and throughout the protocol (P Ͻ 0.021). Forearm cutaneous vascular resistance was greater than baseline at several time points in LNBPϩFC (P Ͻ 0.044). During LBNPϩFC, forearm cutaneous vascular resistance was greater than LBNPϩSham after 3 min of face cooling (P Ͻ 0.022).
During LBNPϩSham, fingertip cutaneous vascular resistance was not different from baseline at any point (P Ͼ 0.915) ( Fig. 4D ). During LBNPϩFC, fingertip cutaneous vascular resistance was greater than baseline at 9 and 12 min of face cooling (P Ͻ 0.007). Between conditions, fingertip cutaneous vascular resistance was greater during LBNPϩFC than LBNPϩSham at minutes 7, 12, 15, 18, 21 , and Post (P Ͻ 0.025).
DISCUSSION
The main finding of this study is that face cooling facilitated a rapid increase in mean arterial pressure that was sustained throughout 15 min of 30 mmHg of LBNP. The increase in mean arterial pressure during face cooling was accomplished by a combination of increases in cardiac output and skin vascular resistance. These findings indicate that face cooling is able to augment mean arterial pressure during a central hypovolemic challenge, which suggests that this technique could be employed as a tool to prevent or delay cardiovascular decompensation during central hypovolemia.
Face cooling during 2 min of 30 mmHg of LBNP has been shown to prevent mean arterial pressure from decreasing by~8 mmHg in healthy participants (8) . However, we observed substantial increases in mean and systolic blood pressure throughout 15 min of LBNPϩFC when compared with LBNPϩSham (Fig. 2, A and B) . Whole body surface skin cooling increases mean arterial pressure by~7-8 mmHg during 30 mmHg (14, 30), 40 mmHg (12, 14) , and 50 mmHg (14, 31) of LBNP. Inspiratory threshold devices increase mean arterial pressure by 22-28 mmHg during LBNP (11, 35, 36) . In this context, it is thought that raising blood pressure during moderate levels of LBNP would help stabilize hemodynamics during more severe central hypovolemia and improve LBNP tolerance. However, evidence to support this idea is not entirely clear and could be dependent on the method and/or timing of increasing mean arterial pressure. For instance, the application of whole body surface skin cooling before and during progressive LBNP improves LBNP tolerance by~34% (14) . Using an inspiratory threshold device throughout progressive LBNP also improves tolerance by 12-23% (11, 35, 36) , whereas applying whole body surface skin cooling after 10 min of 30 mmHg of LBNP followed by progressive LBNP with continued whole body surface skin cooling does not improve LBNP tolerance (30) . It is currently not known whether the increase in blood pressure we observed during LBNPϩFC or the timing of the face cooling application during progressive and more severe central hypovolemia will improve LBNP tolerance. Stimulating the trigeminal nerve using face cooling causes a transient increase in cardiac parasympathetic activity that lasts 2-3 min (17, 37). However, when facial cooling was applied during LBNP, the increase in cardiac parasympathetic activity above baseline values persisted for 6 min (Fig. 3D) . Moreover, cardiac parasympathetic activity during LBNPϩFC was greater than LBNPϩSham for 12 min. The increase in cardiac parasympathetic activity decreased heart rate during face cooling (Fig. 3A) , which most likely allowed for an increase in end-diastolic volume (1, 47) . We speculate that the increase in end-diastolic volume during face cooling improved the FrankStarling relationship that prevented the fall in stroke volume during LBNPϩFC (Fig. 3B) . Although heart rate was lower during LBNPϩFC than LBNPϩSham, the augmented stroke volume during LBNPϩFC prevented the fall in cardiac output that was seen during LBNPϩSham. Therefore, the greater cardiac output during LBNPϩFC contributed to the increases in both systolic and mean arterial pressure.
In addition to augmenting cardiac parasympathetic activity, facial cooling also causes robust increases in sympathetic nerve activity (17, 19, 39 ) that translate to increased resistance in a variety of vascular beds (5, 16, 17, 20, 29) . It is currently not known whether sympathetic activity (i.e., muscle or skin sympathetic nerve activity) is increased beyond 3 min of face cooling (17, 19, 39) . However, our previous study demonstrates that forearm vascular resistance can be augmented for up to 15 min during face cooling (37) , which suggests that sympathetic activity is elevated throughout the duration of face cooling. Although we did not observe further sustained increases in total peripheral resistance and forearm vascular resistance during LBNPϩFC, we did observe increases in forearm and fingertip cutaneous vascular resistance, which primarily occurred during the latter portions of LBNPϩFC (minute 9 through Post, and minute 7 and minutes 12 through Post, respectively) (Fig. 4, C and D) . These results indicate that skin sympathetic vasoconstrictor nerve activity is likely increased during LBNPϩFC. Furthermore, we speculate that the increases in skin vascular resistance offset a potential reduction in vascular resistance to vital organs during LBNPϩFC, which resulted in no differences in total peripheral resistance between LBNPϩFC and LBNPϩSham. However, additional work is needed to discern whether increases in skin vascular resistance during LBNPϩFC cause a redistribution of blood flow to mitigate decreases in central blood volume.
Experimental considerations. Our study has several limitations worth noting. First, we did not take participants to LBNP tolerance. This would have provided valuable applied information regarding the capability of face cooling to prevent or delay cardiovascular decompensation during severe central hypovolemia (i.e., blood loss). Nonetheless, we have provided evidence that face cooling during a constant moderate level of LBNP increases blood pressure. Second, we did not control for menstrual cycle hormones. Because the timing of hypotensive states (e.g., trauma-induced blood loss, and sepsis) is unpredictable, we chose not to control for menstrual cycle hormones despite their influence on blood pressure regulation (28) and sympathetic responses to LBNP (7, 45) . Third, we did not quantify cardiovascular fitness or exercise training status in our participants, which has been shown to influence hemodynamic responses to LBNP (24, 26, 32, 33, 42) . Fourth, blood loss is commonly associated with hypothermia (6), which can lead to coagulopathy (4). However, we currently do not know whether face cooling influences coagulopathy in hypothermic trauma patients. Finally, we did not clamp respiratory rate or tidal volume between conditions, which could have influenced our measure of cardiac parasympathetic activity (i.e., RMSSD) (43) . Currently, the interaction between face cooling and LBNP on ventilatory pattern and stability is not known.
Conclusions. We have demonstrated that face cooling during moderate LBNP increases mean arterial pressure throughout the duration of face cooling. The increase in mean arterial pressure during LBNP was accomplished by increases in both cardiac output and skin vascular resistance. Moreover, the application of face cooling during LBNP provoked temporal increases in cardiac parasympathetic activity and sympathetic activity, both of which contributed to the increase in mean arterial pressure. 
Perspectives and Significance
Blood loss is the leading cause of civilian and battlefield trauma deaths (15) . Approximately 91% of potentially survivable deaths on the battlefield are blood loss-related (15, 23) , and it is estimated that~25% of these deaths could have been prevented by timely intervention and treatment. These preventable deaths underscore the need for rapid and simple prehospital interventions to maintain or restore blood pressure before and during transport or evacuation (2) . This study is the first step toward the possibility of using face cooling to mitigate cardiovascular decompensation during blood loss or other conditions involving central hypovolemia. Combat medics and first responders could carry chemical ice packs in their medic bags and apply them to a patient's forehead following blood loss. However, we believe that using forehead cooling to prevent cardiovascular decompensation is situational. For instance, if active bleeding is occurring, either internal or external, a further increase in blood pressure could only be used after the bleeding is controlled. Furthermore, it is common for medical personnel to allow blood pressure to remain low (i.e., permissive hypotension) before the addition of fluid to prevent the rupture of newly formed blood clots (41) . It remains to be seen, however, if face cooling can be titrated to maintain blood pressure within acceptable values. This would require an understanding of the dose-response relationship between the magnitudes of face cooling and increases in blood pressure. Moreover, it is also unclear how additional environmental factors that are commonly encountered by military and emergency personnel, such as heat stress, cold stress, hypoxia, and prior exercise, influence the pressor response to face cooling during blood loss. In this context, simultaneous stimulation of both the sympathetic and parasympathetic nervous systems (i.e., "autonomic conflict") due to blood loss and face cooling, respectively, could contribute to an increased risk of cardiac arrhythmias in some patients (3, 40, 44) . Consequently, further research is needed to determine whether face cooling is feasible for the prevention of cardiovascular decompensation during blood loss, or other central hypovolemic challenges, in a variety of environmental and physiological conditions.
